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Abstract
Lactic acidosis (LA) is a marker for mortality in severe malaria, but the mechanisms that
lead to LA in the different types of severe malaria and the extent to which LA-associated
mortality differs by type of severe malaria are not well described. We assessed the fre-
quency of LA in children admitted to Mulago Hospital, Kampala, Uganda with cerebral
malaria (CM, n = 193) or severe malarial anemia (SMA, n = 216). LA was compared to mor-
tality and measures of parasite biomass and sequestration (P. falciparum histidine-rich pro-
tein-2 (PfHRP2) concentration, platelet count), and to a measure of systemic tissue oxygen
delivery (hemoglobin level). LA was more frequent in children with SMA than CM (SMA,
47.7%, CM, 34.2%, P = 0.006), but mortality was higher in children with CM (13.0%) than
SMA (0.5%, P<0.0001). In CM, LA was associated with increased PfHRP2 concentration
and decreased platelet count but was not associated with hemoglobin level. In contrast, in
SMA, LA was associated with a decreased hemoglobin level, but was not associated with
PfHRP2 concentration or platelet count. LA was related to mortality only in CM. In multivari-
able regression analysis of the effect PfHRP2 and hemoglobin levels on LA and DB, only
PfHRP2 level increased risk of LA and DB in CM, while in SMA, elevated hemoglobin
strongly decreased risk of LA and DB, and PfHRP2 level modestly increased risk of LA.
The study findings suggest that LA in CM is due primarily to parasite sequestration, which
currently has no effective adjunctive therapy, while LA in SMA is due primarily to anemia,
which is rapidly corrected with blood transfusion. Differing etiologies of LA in CM and SMA
may explain why LA is associated with mortality in CM but not SMA.
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Introduction
TheWorld Health Organization estimates that in 2015 there were 214 million new cases of
malaria and 438,000 deaths [1]. 90% of these deaths occurred in sub-Saharan Africa, 77% were
children under the age of 5, and 66% occurredwithin 24 hours of hospital admission[1, 2]. Lac-
tic acidosis (LA) has been useful as a marker of disease severity in other infectious disease pro-
cesses such as sepsis [3], and has been associated with mortality in multiple studies of severe
malaria [4–7]. Since measurement of LA requires diagnostic equipment not available in many
health centers in sub-Saharan Africa, researchers have assessed whether a clinical proxy would
provide similar information. Respiratory distress (RD), a summary diagnosis comprised of
nasal flaring, chest in-drawing, intercostal recessions, and deep breathing (DB) correlated
strongly with LA [8], and studies by English et al investigating each component of RD sepa-
rately found that DB was the most sensitive and specific indicator of severe metabolic acidosis
in children with severe malaria [9]. The observationwas confirmed by the SevereMalaria in
African Children (SMAC) network, a network comprising more than 14,000 children in 3
countries, which found DB to be one of three clinical signs used in the Lambaréné organ dys-
function score to predict mortality in hospitalized patients with malaria [10].
Studies to date on the associations between LA, DB or RD and mortality have assessed chil-
dren with severe malaria as a single clinical entity and have not assessed risks in the different
types of severe malaria independently. Severemalarial anemia (SMA) is among the most com-
mon forms of severe malaria, with an estimated 1.5 to 5 million children affected annually [11].
Reportedmortality rates in SMA vary widely from 1.7% [12] to 9% [13], and are consistently
lower than the mortality rates for cerebral malaria (CM), which is less common but more often
fatal, with an average 18.6%mortality [14]. Diverse etiologies can lead to acidosis in children
suffering from different forms of severe malaria, so the reversal of LA requires knowledge of
what is causing the LA. Potential contributors to LA in children include local tissue parasite
sequestration, with resulting localized ischemia, which may occur in any form of severe
malaria, but is likely most pronounced in CM, and systemic impairment of oxygen delivery
due to low hemoglobin levels, which is most common in SMA.
To resolve the questions of how LA, RD and DB relate to each other, how they differ in two
of the most common forms of severe malaria, how mortality with each factor differs, and
which processes contribute to LA, RD and DB in each form of severe malaria, we assessed LA,
RD and DB, along with markers of parasite biomass and sequestration and markers of systemic
perfusion and oxygen delivery in a cohort of Ugandan children with CM or SMA.
Methods
Study Population
The study was performed at Mulago Hospital, Kampala, Uganda. The primary goal of the
study was to assess the presence of neurocognitive impairment in children with CM or SMA,
and pathogenesis of disease in these two forms of malaria. Children with CM, or SMA were
enrolled if they were between 18 months and 12 years of age. CM was defined as: 1) coma
(Blantyre Coma Score [BCS]2 or Glasgow Coma Score [GSC]8); 2) Plasmodium falciparum
on blood smear; 3) no other known cause of coma (e.g., meningitis, a prolonged postictal state
or hypoglycemia-associated coma reversed by glucose infusion). SMA was defined as presence
of Plasmodium falciparum on blood smear in children with hemoglobin level 5 g/dL. Hemo-
globin was measured by photometry (HemoControl; EKF Diagnostics). Exclusion criteria for
all children included: 1) known chronic illness requiringmedical care; 2) known developmental
delay; or 3) prior history of coma, head trauma, hospitalization for malnutrition, or cerebral
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palsy. Additional exclusion criteria for children with SMA included 1) impaired consciousness
to any degree on physical exam (BCS<5); 2) other clinical evidence of CNS disease; or 3)>1
seizure prior to admission.
Children with CM or SMA were managed according to the Ugandan Ministry of Health
treatment guidelines current at the time of the study. These included initial intravenous qui-
nine treatment followed by oral quinine for severe malaria while admitted, artemisinin combi-
nation therapy for outpatient follow-up therapy, and blood transfusion for all children with a
hemoglobin5 g/dL (which included all children with SMA, including children with concur-
rent CM and SMA).
Clinical and laboratory assessment
Respiratory distress (RD) was defined as the presence of acidotic breathing, nasal flaring, inter-
costal recessions, or chest indrawing, and deep breathing (DB) was defined solely by the pres-
ence of deep acidotic breathing. Plasma P. falciparum histidine-rich protein-2 (PfHRP2) levels
were tested to assess parasite biomass and sequestration [15], and platelet counts measured to
assess for platelet contribution to sequestration [16]. To assess systemic perfusion and oxygen
delivery, hemoglobin levels and oxygen saturation were assessed.
On admission, venous bloodwas collected for microscopy and lactate measurement. Blood
smears for microscopy were Giemsa stained and read independently by two readers, with dis-
cordant results resolved by a third reader. Lactate was measured using a point of care lactate
analyzer (Accutrend lactate meter, Roche Diagnostics,Mannheim, Germany). Lactic acidosis
was defined as a blood lactate level> 5.0 mmol/L. Plasma PfHRP2 levels were quantified using
the commercially available Malaria Ag CELISA kit (Cellabs, Brookvale, Australia). The enzyme
linked immunosorbent assays were performed according to the manufacturer’s protocol with
optical density (OD) determined at 450 and 620 nm. Plasma was diluted 1:2400 in the kit-pro-
vided 1X PBS/Tween buffer (PBST). Samples with results above or below the range of the stan-
dard curvewere retested at a dilution of 1:24,000 or 1:200, respectively. To assess intra-assay
repeatability, 10% of samples (from a mix of study groups) from each assay plate were repli-
cated on subsequent plates. The coefficient of variation for these samples was 19.6%. Total, cir-
culating and sequestered parasite biomass were calculated using a formula adapted from
Dondorp et al. [17] and Cunnington et al [18], in which total parasite biomass is 7.3 PfHRP2
(1- (hematocrit0.01))weight(10^7), circulating biomass is parasite density(10^6)
(0.08weight), and sequestered parasite biomass is total biomass–circulating biomass.
Data Analysis
Data was entered into a FileMaker Pro 11 database (FileMaker Inc, Santa Clara, CA), and
exported to and analyzed in Stata SE 12 (Stata Corporation, College Station, TX). Categorical
variables were analyzed using the chi-squared test, and continuous variables were assessed
using theWilcoxon rank sum test. Logistic regression was used to explore the predictive power
of LA, RD or DB on mortality. PfHRP2 levels and platelet count were not normally distributed
and so were natural log transformed for regression analysis.
Ethical approval
Written informed consent was obtained from parents or guardians of study participants. The
Institutional ReviewBoards for human studies at Makerere University School of Medicine and
the University of Minnesota granted ethical approval for the study.
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Results
Demographic, clinical and laboratory findings in children with CM
compared to children with CM and SMA
A total of 269 children with CM and 233 children with SMA were enrolled in the study. 1 child
with CM and 1 with SMA left the hospital against medical advice, and 19 children with CM
and 16 children with SMA did not have lactate level measured. Analysis was done on the
remaining 249 children with CM and 216 children with SMA (Fig 1). Children with CM or
SMA who had LAmeasured did not differ from those who did not have LAmeasured in terms
of mortality (CM, 12.4% vs. 15.8%, P = 0.7; SMA, 0.5% vs 0%, P = 1.0) or frequency of deep
breathing (CM, 8.8% vs. 10.5%, P = 0.7. SMA, 7.4% vs. 0%, P = 0.6).
Of the 249 children with CM, 56 had concurrent SMA. Children with CM and concurrent
SMA differed from children with CM alone in several aspects: they were significantly younger,
and had more frequent respiratory distress and deep breathing, lower hemoglobin levels,
higher PfHRP2 levels, and lower peripheral P. falciparum parasite density than children with
CM alone (S1 Table). Despite these differences,mortality did not differ between children with
CM alone (13.0%) and children with CM and SMA (10.7%). Because we wanted to explore
how risk factors differed specifically in CM as compared to SMA, primary analysis was con-
ducted comparing children with CM and no SMA (n = 193) to children with SMA alone (none
of whom had CM). The subsequent analyses refer to these groups, but S1–S5 Tables describe
the same findings as Tables 1–5 for children with both CM and SMA compared to children
with CM alone.
Demographic, clinical and laboratory findings in children with CM as
compared to children with SMA
More than 60% of children with CM or SMA were male, and children with CMwere signifi-
cantly older than children with SMA. Mortality was significantly higher in children with CM
(13.0%) than in children with SMA (0.5%, P<0.0001, Table 1). DB occurred at similar frequen-
cies in children with CM or SMA, but LA was more common and lactic acid levels were higher
in children with SMA than CM (Table 1). Children with CM had higher PfHRP2 levels, higher
peripheral P. falciparum parasite density, and lower platelet count (all factors associated with
Fig 1. Study enrollment and testing for lactic acidosis.
doi:10.1371/journal.pone.0163728.g001
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parasite biomass and sequestration) than children with SMA, while children with SMA had
lower hemoglobin levels (associated with less systemic tissue oxygen delivery) than children
with CM. Children with CM had higher total, circulating and sequestered parasite biomass
than children with SMA (Table 2).
Risk factors for deep breathing (DB) and lactic acidosis (LA) in children
with CM as compared to children with SMA
Children with CMwho had DB or LA had markers of increased parasite biomass and seques-
tration (higher PfHRP2, lower platelet count) compared to children with CM and no DB or
LA, but the groups did not differ in hemoglobin levels (Table 3). In contrast, children with
SMA and DB or LA had lower hemoglobin levels than children with SMA and no DB or LA,
but the groups did not differ in markers of increased parasite biomass or sequestration
(Table 3). Supporting this association, lactate levels were inversely correlated with hemoglobin
level in children with SMA (Spearman’s rho = -0.3, P<0.0001) but not in children with CM
(Spearman’s rho = -0.07, P = 0.3). Multivariable regression analysis of hemoglobin and log-
transformed PfHRP2 showed that for children with CM, only increased PfHRP2 correlated
with an increased risk of LA or DB (odds ratio (OR) [95% confidence interval (CI)], LA:
PfHRP2, 1.54 [1.20, 1.99], P = 0.001, hemoglobin, 0.97 [0.82, 1.15], P = 0.76; DB: PfHRP2, 2,67
[1.48, 4.82], P = 0.001, hemoglobin, 0.97 [0.67, 1.40], P = 0.86). For children with SMA, ele-
vated hemoglobin strongly decreased risk of LA, but increased PfHRP2 level was less strongly
associated with an increased risk of LA (PfHRP2, 1.25 [1.05, 1.48], P = 0.01, hemoglobin, 0.39
[0.28, 0.57], P<0.001), and similarly elevated hemoglobin decreased and elevated PfHRP2
increased the risk of DB, the latter just shy of statistical significance (PfHRP2, 1.45 [0.98, 2.16],
P = 0.06, hemoglobin, 0.48 [0.25, 0.90], P = 0.02). In children with both CM and SMA, neither
hemoglobin level nor PfHRP2 was significantly associated with LA or DB (OR [95% CI], LA:
Table 1. Demographic, clinical and laboratory findings children with cerebral malaria alone (CM) or severe malarial anemia alone (SMA) on
admission.
Characteristic or finding CM SMA Pa
N = 193 N = 216
Age in years, mean (SD) 4.2 (2.0) 3.4 (1.7) <0.0001
Sex, N female (%) 75 (38.9) 84 (38.9) 0.9
Mortality, N (%) 25 (13.0) 1 (0.5) <0.0001
Respiratory distress, N (%) 47 (24.4) 65 (30.1) 0.2
Deep breathing, N (%) 12 (6.2) 16 (7.4) 0.6
Lactic acidosisb, N (%) 66 (34.2) 103 (47.7) 0.006
Blood lactate, mmol/L, median (IQR) 3.8 (2.3, 6.5) 4.8 (2.9, 8.1) 0.001
Hemoglobin, g/dL, mean (SD) 7.8 (1.9) 3.7 (0.9) <0.0001
O2 Saturation, median (IQR) 97 (94, 99) 98 (95, 99)c 0.5
O2 Saturation, <92%, N (%) 19 (9.8) 15 (6.9)c 0.3
Platelet count, 109/L, median (IQR) 56 (35, 103)c 154 (96, 234)c <0.0001
PfHRP2, 103ng/mL, median (IQR) 2,561 (881, 5,148) 881 (367, 2,581)c <0.0001
Peripheral blood P falciparum density, parasites/μL, median (IQR) 53,120 (13,980, 340,770)c 35,740 (10,100, 156,040)c 0.005
a P-value for continuous variables compared by Students’ t-test if normally distributed and Wilcoxon rank-sum if skewed distribution, and for categorical
variables by χ2 or Fisher’s exact test where appropriate
b Lactic acidosis defined as blood lactate > 5.0 mmol/liter
c N differs from total N and is noted in S6 Table
doi:10.1371/journal.pone.0163728.t001
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PfHRP2, 1.27 [0.76, 2.13], P = 0.36, hemoglobin, 0.57 [0.27, 1.21], P = 0.15; DB: PfHRP2, 0.83
[0.46, 1.47], P = 0.52, hemoglobin, 0.92 [0.37, 2.30], P = 0.86)).
In children with CM, total and sequestered parasite biomass were both higher for children
with DB or LA. Circulating biomass was higher in children with LA and showed a trend toward
increase in children with DB (P = 0.07, Table 2). In children with SMA, values for total, circu-
lating, and sequestered parasite biomass did not differ significantly in children with vs. without
DB, but children with SMA and LA did have higher total parasite biomass than children with-
out LA, and children with SMA and LA also showed a trend toward higher sequestered parasite
biomass (P = 0.07, Table 2).
Risk factors for mortality in children with CM
Risk factors for mortality were assessed only in children with CM. (Lowmortality in children
with SMA precluded analysis of risk factors). A higher proportion of children with CMwho
died had DB and LA than CM survivors, and children with CMwho died showed markers of
greater parasite biomass and sequestration (higher PfHRP2 levels, lower platelet counts) than
Table 2. Parasite biomass.
CM SMA Pa
N = 166 N = 179
Total parasite biomass x 108, median (IQR) 17,427 (5,747, 37,523) 7,572 (2,371, 18,214) <0.0001
Circulating parasite biomass x 108, median (IQR) 643 (170, 3,814) 410 (124, 1,676) 0.004
Sequestered parasite biomass x 108, median (IQR) 13,717 (4,628, 32,886) 5,963 (1,546, 16,177) <0.0001
CM Deep Breathing CM No Deep Breathing
N = 9 N = 157
Total parasite biomass x 108, median (IQR) 44,831 (19,859, 202,395) 16,610 (5,314, 34,895) 0.01
Circulating parasite biomass x 108, median (IQR) 3,534 (868, 7,583) 588 (169, 3,574) 0.07
Sequestered parasite biomass x 108, median (IQR) 32,525 (16,325, 197,712) 13,273 (4,535, 30,851) 0.02
CM lactic acidosis CM No lactic acidosis
N = 57 N = 109
Total parasite biomass x 108, median (IQR) 21,460 (11,688, 42,333) 15,019 (3,792, 32,887) 0.03
Circulating parasite biomass x 108, median (IQR) 1,092 (327, 4,721) 488 (117, 3,271) 0.05
Sequestered parasite biomass x 108, median (IQR) 16,325 (8,405, 39,820) 12,362 (2,487, 30, 851) 0.05
SMA Deep Breathing SMA No Deep Breathing
N = 9 N = 170
Total parasite biomass x 108, median (IQR) 6,910 (5,238, 32,009) 7,677 (2,251, 17,364) 0.3
Circulating parasite biomass x 108, median (IQR) 869 (378, 2,769) 397 (119, 1,597) 0.1
Sequestered parasite biomass x 108, median (IQR) 6,249 (3,322, 28,502) 5,892 (1,546, 16,030) 0.6
SMA lactic acidosis SMA No lactic acidosis
N = 75 N = 104
Total parasite biomass x 108, median (IQR) 8,620 (2,904, 22,886) 6,260 (2,215, 14,081) 0.05
Circulating parasite biomass x 108, median (IQR) 400 (99, 1,731) 427 (133, 1,636) 1.0
Sequestered parasite biomass x 108, median (IQR) 8,001 (2,056, 22,334) 5,109 (1,471, 12,515) 0.07
CM Died CM Survived
N = 22 N = 144
Total parasite biomass x 108, median (IQR) 33,493 (13,481, 52,668) 16,351 (5,208, 32,983) 0.008
Circulating parasite biomass x 108, median (IQR) 1,069 (242, 3,240) 578 (170, 4,111) 0.8
Sequestered parasite biomass x 108, median (IQR) 31,957 (12,290, 51,668) 13,011 (3,197, 29,789) 0.006
a P-value for Wilcoxon rank-sum
doi:10.1371/journal.pone.0163728.t002
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children who survivedCM (Table 4). Total and sequestered but not circulating parasite bio-
mass were higher in children with CMwho died than in those who survived (Table 2). We fur-
ther assessed how DB and LA, alone or in combination, related to mortality in children with
CM (Table 5). Children with DB (all of whom had LA) had the highest mortality rate (50.0%).
Children with LA and no DB had a similar mortality rate to the overall cohort of children with
CM (13.0%), and mortality was modestly lower in children without DB (10.2%) or without LA
(9.5%). Among children with CMwho received a transfusion, transfusion was not associated
with a decrease in mortality (data not shown).
In a regression model including all factors associated with mortality (DB or LA, PfHRP2
level and platelet count), only DB was significantly associated with mortality (OR 4.3, 95% CI
1.1–17.1). Of note, the one child with SMA who died had neither DB nor LA (Table 3).
Discussion
In the present study, we show that LA occurs at similar frequency in CM and SMA, but corre-
lates with mortality only in CM.We also show that the pathophysiologic correlates of LA are
Table 3. Levels of disease pathogenesis markers in children with cerebral malaria and severe malaria anemia with vs. without deep breathing or
lactic acidosis.
Cerebral Malaria
Deep breathing No deep breathing Pa
N = 12 N = 181
Platelet Count 109/L, median (IQR) 34 (14, 43)b 59 (35, 108)b 0.008
PfHRP2103ng/ml, median (IQR) 7,291 (3,550, 19,175) 2,486 (812, 4,894) 0.0005
Hemoglobin, g/dL, mean (SD) 7.2 (1.5) 7.8 (2.0) 0.3
Peripheral blood P falciparum Densityb 365,840 (47,880, 789,940)c 49,765 (13,100, 295,060)c 0.05
Lactic acidosis No lactic acidosis
N = 66 N = 127
Platelet Count 109/L, median (IQR) 42 (28, 62)c 65 (38, 130)c 0.0003
PfHRP2 103ng/ml, median (IQR) 3,335 (1,680, 7,281) 2,244 (542, 4,507) 0.0005
Hemoglobin, g/dL, mean (SD) 7.5 (2.0) 7.9 (1.9) 0.2
Peripheral blood P falciparum Densityb 114,240 (29,000, 448,360)c 42,890 (10,220, 248,210)c 0.009
Severe Malaria Anemia
Deep breathing No deep breathing Pa
N = 16 N = 200
Platelet Count 109/L, median (IQR) 175 (118, 347) 151 (95, 226)b 0.3
PfHRP2103ng/ml, median (IQR) 1,387 (515, 3,264)c 848 (312, 2,578)c 0.2
Hemoglobin, g/dL, mean (SD) 3.3 (0.9) 3.8 (0.9) 0.03
Peripheral blood P falciparum Densityb 37,570 (1,506, 256,710) 35,180 (10,660, 151,760)c 0.8
Lactic acidosis No lactic acidosis
N = 103 N = 113
Platelet Count 109/L, median (IQR) 160 (96, 281)c 148 (94, 224)c 0.7
PfHRP2 103ng/ml, median (IQR) 952 (312, 3,134)c 865 (371, 2,065)c 0.2
Hemoglobin, g/dL, mean (SD) 3.4 (0.9) 4.0 (0.7) <0.0001
Peripheral blood P falciparum Densityb 32,983 (3,110, 123,180)c 41,360 (12,380, 178,020) 0.3
a P-value for continuous variables compared by Students’ t-test if normally distributed and Wilcoxon rank-sum if skewed distribution, and for categorical
variables by χ2 or Fisher’s exact test where appropriate
b Parasites/μL, median (IQR)
c N differs from total N and is noted in S6 Table.
doi:10.1371/journal.pone.0163728.t003
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different in the two forms of severe malaria: in CM, LA correlates with increased parasite bio-
mass and decreased platelet count, both factors associated with infected red blood cell seques-
tration, while in SMA, DB and LA primarily correlate with lower hemoglobin level, a factor
associated with impaired tissue oxygen delivery, and correlate to a lesser extent with parasite
biomass. The study findings suggest that in CM, LA is associated with greater parasite seques-
tration, for which there is currently no effective adjunctive therapy, while in SMA, LA is pri-
marily associated with anemia and consequent impaired tissue oxygen delivery, which are
rapidly correctedwith blood transfusion. The differing primary etiologies of LA in CM and
SMAmay explain why LA is associated with mortality in CM but not SMA, and suggest that
interventions to address LA in children with severe malaria must address the underlying cause
of LA, which may differ in the different forms of severe malaria.
Table 4. Demographic, clinical and laboratory findings children with cerebral malaria (CM) who survived vs. died.
Characteristic or finding Died Survived Pa
N = 25 N = 168
Age in years, mean (SD) 3.5 (1.7) 4.3 (2.1) 0.08
Sex, N (% female) 10 (40.0) 65 (38.7) 0.9
Respiratory distress, N (%) 9 (36.0) 38 (22.6) 0.1
Deep breathing, N (%) 6 (24.0) 6 (3.6) <0.0001
Lactic acidosisb, N (%) 13 (52.0) 53 (31.6) 0.04
Blood lactate, mmol/L, median (IQR) 5.1 (2.8, 7.8) 3.7 (2.2, 6.2) 0.09
Hemoglobin, g/dL, mean (SD) 8.2 (1.8) 7.7 (2.0) 0.3
O2 Saturation, median (IQR) 96 (93, 98) 98 (95, 99) 0.07
O2 Saturation <92%, n (%) 5 (20.0) 14 (8.3) 0.07
Platelet count, 109/L, median (IQR) 41 (17, 62)c 60 (35, 110)c 0.02
PfHRP2, 103ng/mL, median (IQR) 4,514 (1,598, 7,517) 2,389 (834, 4,921) 0.02
Peripheral blood P falciparum densityd, 83,680 (21,240, 340,770)c 48,640 (12,920, 368,820)c 0.5
a P-value for continuous variables compared by Students’ t-test if normally distributed and Wilcoxon rank-sum if skewed distribution, and for categorical
variables by χ2 or Fisher’s exact test where appropriate
b Lactic acidosis defined as blood lactate > 5.0 mmol/liter
c N differs from total N and is noted in S6 Table
d Parasites/μL, median (IQR)
doi:10.1371/journal.pone.0163728.t004
Table 5. Mortality in children with cerebral malaria (CM) or severe malarial anemia (SMA) in the presence or absence of deep breathing and lactic
acidosis.
CM SMA
N = 193 N = 216
Finding N with factor % with factor Mortality with factora N with factor % with factor Mortality with factora
All children 193 - 25 (13.0) 216 - 1 (0.5)
DB 12 6.2 6 (50.0) 16 7.4 0
LA 66 34.2 13 (19.7) 103 47.7 0
DB and LA 12 6.2 6 (50.0) 15 6.9 0
DB without LA 0 0 0 1 0.5 0
LA without DB 54 28.0 7 (13.0) 88 40.7 0
No DB 181 93.8 19 (10.5) 200 92.6 1 (0.5)
No LA 127 65.8 12 (9.5) 113 52.3 1 (0.9)
a N (%)
doi:10.1371/journal.pone.0163728.t005
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Multiple pathophysiologic processes can lead to LA. In studies of lactic acidosis in sepsis,
for example, pathways that lead to LA include factors that lead to systemic or regional hypoxia,
as well as factors not associated with hypoxia, such as underlying organ disease, drugs and tox-
ins, and inborn errors of metabolism [19]. In the present study, LA appears to be associated
with processes leading to systemic hypoxia in SMA and localized hypoxia and ischemia in CM.
The present study and others have shown that prompt blood transfusions can reverse the inad-
equate O2 delivery associated with LA or DB in patients with SMA and will lead to resolution
of LA and low mortality rates [20, 21]. The pathophysiology of platelet adhesion and parasite
sequestration, however, is not easily reversed. As a result, LA and DB in CM have been associ-
ated with a significantly higher mortality rate in multiple studies of African children [7, 22, 23].
In sepsis and other illnesses, interventions specifically addressing the elevated lactate concen-
tration or acidosis, such as administration of dichloroacetate [24] or bicarbonate [25], have not
resulted in improved survival, even though in the case of dichloroacetate, acidemia improved.
Dichloroacetate decreasedmortality in an animal model of severe malaria [26], but the studies
in sepsis and the findings of the present study suggest that interventions that can decrease or
reverse the underlying cause of LA, presumably the sequestration process in children with CM,
are likely to have greater benefit than interventions like dicholoroacetate. Trials of interven-
tions that could decrease sequestration, e.g., low anticoagulant heparin derivatives [27], are
therefore urgently needed, as they have the potential to decreasemortality and morbidity in
CM.
In the present study, we show that parasite biomass appears to play a role in both CM and
SMA, as total and sequestered biomass were higher in children with LA than without LA in
both groups. However, thrombocytopenia was associated with LA only in children with CM.
Laboratory studies have shown that platelets aid in the cytoadhesion of parasitized red blood
cells and could be pathologically important to cerebral malaria [16, 28]. Post mortem studies of
children with CM confirm these findings, reporting a significant increase of platelets in the
brain microvasculature of children with CM as compared to children without it [29], and
involvement of monocytes in platelets in sequestration in children with fatal CM [30]. The
association of thrombocytopeniawith LA in CM but not SMA in the present study is consistent
with a contribution of platelet adhesion to sequestration in the brain and other organs, and
supports the idea that sequestration, involving not only sequestered parasites but platelet adhe-
sion and likely leukocyte adhesion (a factor more difficult to measure in peripheral blood sam-
ples), leads to LA in CM. Sequestration could also play a role in the LA seen in SMA, but the
strong correlation of hemoglobin level with LA in SMA and not CM, and the low mortality in
SMA with blood transfusion, both suggest that the primary cause of LA in SMA is a low hemo-
globin level and the resulting systemic hypoxia and not sequestration. Children with both CM
and SMA did not have significant associations of either hemoglobin level or PfHRP2 level with
LA or DB, but the strongest association seen was of elevated hemoglobin with a decreased risk
of LA (hemoglobin, OR, 95% CI, 0.57 [0.27, 1.21], P = 0.15), suggesting that children with both
CM and SMA, LA is more strongly related to hemoglobin level than parasite biomass, i.e., that
LA is drivenmost by the SMA component in these children.
Studies in malaria have shown a stronger relationship of base deficit than LA with mortality
[31], and recent studies have shown the presence of previously unmeasured organic acids are
also associated with mortality in Asian adults with severe malaria [32]. In the present study,
the presence of DB but not RD was significantly associated with mortality in children with CM
(P =<0.0001 and P = 0.1 respectively), confirming the observations of English et al [9] and the
SevereMalaria in African Children (SMAC) network [10], that DB is the most useful respira-
tory sign in predictingmortality in children with malaria. DB emerged as the only independent
risk factor for death when included in a multivariable regression model with PfHRP2 and
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platelet count, suggesting that the clinical manifestation of DB may be an “end pathway” result
of the sequestration reflected by high PfHRP2 levels and low platelet counts.
The low mortality rate in children with SMA and LA in the present study, similar to that of
a previous study of Ugandan children with SMA and LA (mortality 1.4%), demonstrates the
benefit of rapid effective transfusion in SMA. In contrast, the similar mortality rates of children
with CM in the present study (13.0%) and in an observational study published twenty years
ago (16.8%) [33] show the need for effective adjunctive therapy in CM.
DB/metabolic acidosis alone, even in the absence CM or SMA, is an important form of
severe malaria. The present study design did not include children with this form of severe
malaria, but an ongoing study by our group in Uganda does include children with DB/met-
abolic acidosis as well as children with CM and SMA. When this study is completed, we
will be able to compare the contribution of parasite biomass and hemoglobin to DB/LA and
mortality in the three major forms of severe malaria: CM, SMA and DB/LA without CM or
SMA. In this ongoing study, we are also assessing base deficit in addition to LA and DB, as
this measure directly assesses acidosis from multiple acids in addition to LA. Our findings
suggest LA may not be a good surrogate marker of mortality in studies of severe malaria
that include SMA, as LA was common in SMA but did not predict mortality in this
condition.
In conclusion, the present study provides evidence that LA and DB are caused by different
primary pathogenic mechanisms in CM and SMA. The differences in mechanisms may explain
why LA and DB are associated with mortality in CM but not SMA. The study findings suggest
that in CM, LA and DB are associated with organ and tissue level sequestration, a process for
which adjunctive therapies are currently unavailable, while in SMA, LA and DB are associated
with anemia and consequent tissue hypoxia, which can be rapidly corrected by blood transfu-
sion. The study findings support continued investigation of interventions to prevent or reduce
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